IMS Health (IMS) Tops Q2 EPS by 6c

IMS Health (NYSE: IMS) reported Q2 EPS of $0.37, $0.06 better than the analyst estimate of $0.31. Revenue for the quarter came in at $742 million versus the consensus estimate of $734.94 million.

For earnings history and earnings-related data on IMS Health (IMS) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Cantor Fitzgerald Reiterates Overweight Rating on Global Net Lease (GNL)
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation